1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional) is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the NIH. This Notice of Funding Opportunity (NOFO) invites applications for Nutrition Obesity Research Centers (NORCs). NORCs provide a synergistic environment for nutrition and obesity research.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
P30: Nutrition Obesity Research Centers Application Resources - NIDDK Nutrition Obesity Research Centers Application Resources (P30) P30: Nutrition Obesity Research Centers Application Resources Most recent NIDDK funding announcement: RFA-DK-25-007 The NIDDK-supported Nutrition Obesity Research Centers (NORC) support extramural research institutions that have established an existing base of high-quality, nutrition and/or obesity-related research.
The program fosters long-term multidisciplinary research in nutrition/obesity, but does not directly fund major research projects; rather, it provides core resources to support the interdisciplinary cooperation of a group of established investigators conducting research in nutrition, obesity, and related topics. For more information about the twelve existing NORCs, see the NORC Central webpage.
Tables for P30 NORC Applications Applicants are strongly encouraged to use the following tables as part of their NORC application. Please download the files (. xlsx formats) and complete them as directed: Table A: Summary of Current and Pending Grant Support of all Center Members (XLSX, <1 MB) Table B: Listing of all Center Members and their Core Facility Use (XLSX, <1 MB) Table C: Collaborations between Center Members (XLSX, 19.
32 KB) Table D: Core facility use (XLSX, 23. 19 KB) Table E: Pilots (XLSX, <1 MB) Table F: Publications by Core (XLSX, <1 MB) October 9, 2024 and June 10, 2025 Last Reviewed October 2024
According to the current listing, eligibility includes: Not specified in snippet, but P30 grants typically support institutions. Confirm the full requirements in the official notice before applying.
Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional) is funded by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the NIH. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs from NIDDK are competitive federal grant programs administered by the National Institute of Diabetes and Digestive and Kidney Diseases supporting innovative research by small businesses with potential for commercialization. NIDDK participates in both SBIR and STTR programs, with funding opportunities aligned to its mission areas in diabetes, digestive diseases, and kidney diseases. Eligible applicants are U.S. small businesses with innovative research applicable to NIDDK's scientific program areas. The NIH SEED website provides comprehensive application guidance and NIDDK-specific program contacts.
NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional) is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the NIH. This program encourages applications to plan multi-center clinical studies. While not specific to bioartificial kidneys, research planning for such complex medical devices would fall under clinical study implementation.
NIDDK High Risk, High Impact Research is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the NIH. NIDDK supports high-risk, high-impact research to advance understanding and treatment of kidney diseases. Development of a bioartificial kidney would be considered high-impact research. This would likely be pursued through general NIH funding mechanisms (e.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article